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ABSTRACT
Background: Benue State has the highest rate of sero-prevalence
to human immuno virus (HIV) infections among the ten
hyper-endemic states in Nigeria. This study evaluates the
pattern of ocular adnexal and anterior segment manifestations
in HIV/AIDS patients attending the HIV clinic at the NAF
Hospital in Makurdi, Benue State and assesses their effects on
the visual functions of the patients.
Methods: This is a hospital-based prospective study of all new
patients who presented at the HIV clinic between October
2007 and March 2008. Ocular and systemic  examinations
were carried out and personal data including  age, sex, place
of abode, occupation and marital status were recorded for each
patient.
Results: A total of 322 patients were seen. The male to female
ratio was 1:1.50. The age range was 4-68 years. The
prevalence rate of anterior segment/ocular adnexal
manifestation was 65.2%. Conjunctival microangiopathy was
the commonest ocular adnexal/anterior segment presentation
constituting 33.8% (highest anterior segment manifestation).
Iridocyclitis constituted 27.14%, while herpes zoster
ophthalmicus accounted for only 3.3% of the cases. The
majority of the patients (95.1%) had normal visual acuity at
presentation to the clinic. Twelve percent had visual
impairment, while 5.0% presented with severe visual
impairment. 
Conclusion:  Conjunctival microangiopathy, iridocyclitis and
molluscum contagiosum were the main anterior segment
lesions observed in this study. Less than 2% of the patients
had severe visual impairment or blindness at presentation to
the clinic.  
Key words: HIV, ocular adnexae, anterior segment, visual
acuity, HIV hyper-endemic state 
INTRODUCTION
Over 45 million people globally are living with the HIV
virus.  The impact of this disease is mostly felt in poor1
countries in Africa and Asia. Sub-Saharan Africa remains the
most seriously affected region, with AIDS still ranking as one
of the leading causes of death. More than half (68%) of all
people who are HIV sero-positive live in sub-Saharan
Africa.  Nigeria is the most populous country in sub-Saharan2
Africa and the 10  most populous in the world. Since theth
first case of AIDS was reported in Nigeria in 1986, the
number of infected persons has been on the increase. The
adult HIV prevalence rate has increased from 1.8% in 1991 to
4.5% in 1996. By 2001, the prevalence rate had increased to
5.8%.  3
Currently about 3.9% of adults between 16 and 49 years
are living with HIV.  Even though the HIV prevalence rate4
in Nigeria is much lower than in the East and South African
countries, Nigeria being the most populous country on the
continent has made HIV syndrome  one of the devastating
medical problems of modern day sub-Saharan Africa. In
South Africa, one out of every five pregnant women is sero-5 
positive for HIV.  The projected population of Burkina Faso
in 2008 is 15.2 million. The adult HIV  prevalence was 1.6%6
in 2007. A population-based study in Uganda  reported an7
HIV prevalence rate of 30% in 1999. However, due to
government intervention, it dropped to 12.16% in 2003.  
Since its emergence in Nigeria, this pandemic has
systemically permeated every community in the country.
The national sero-prevalence rate has increased steadily by
over 200% in the last two decades. HIV/AIDS infection is the
new leading cause of death in Nigeria.  This, coupled with4,8
other social ills such as poverty, has had devastating
consequences on the populace. Benue State, in the north
central zone of Nigeria, is one of the ten hyper-endemic
states for HIV. The state still retains the 1  positionst
nationwide for HIV sero-prevalence.  Prior to the2,4,8
availability of the highly active retroviral therapy, it was as
high as 16.8%. 
Since the initial eye conditions in HIV patients were
reported more than two and a half decades ago, lots of
reports have documented eye disorders affecting an average
of 75% of all patients at some point during the illness.  In9,10
a series by Serraf,  60% of the patients had one form or11
*Correspondence: Dr A Bologi, 45 Nigerian Air Force Hospital, Makurdi, Benue State, Nigeria • Email: drbolotony@yahoo.com
Ocular Adnexal and Anterior Segment Manifestations of HIV/AIDS
another of ocular manifestation of HIV-AIDS. A number of
ophthalmic manifestations of HIV infection involve the
anterior segment.12
Kehinde  reported that herpes zoster ophthalmicus13
(HZO) accounted for 69.6% in a study conducted in north
central Nigeria. This represents the highest ocular finding.
Adegbehingbe  also reported HZO as the commonest ocular14
disease seen in his series. Akinsola, working in Lagos, found
herpes zoster in 54% of HIV cases seen in her study.  Earlier18
studies from the north central,  north west,  east central,13 15 16
and south west zones  of Nigeria reported that ocular17,18,19
adnexal and anterior segment disorders were more prevalent
than posterior segment disorders. Ocular disease occurs at
different stages of HIV infection. In the same vein, earlier
studies have documented regional variations in the spectrum
of eye diseases.  To the best of our knowledge, no previous20
studies have been carried out in the north-central zone of
Nigeria to determine the effects of HIV/AIDS infection on
the eye. The aim of this study, therefore, was to evaluate the
pattern of ocular adnexal and anterior segment manifestation
in HIV/AIDS patients and assess their effects on their visual
functions.
MATERIAL AND METHODS
The study recruited all new patients presenting to the HIV
clinic between October 2007 and March 2008 for the first
time. Visual acuity and ocular examinations were carried out
on each patient with emphasis on the ocular adnexea and
anterior segment using the loupe and slit lamp. Both upper
and lower lids were everted and examined for any
pathology. The lacrimal system was assessed by viewing the
tear film level under the slit lamp. The conjunctival
palpebrae, tarsal and forniceal aspects were all examined
under magnification under the slit lamp and detected
abnormalities were documented. The cornea was examined,
and staining with fluorescien dye was done when indicated.
The anterior chamber and the lens were examined under the
slit lamp. Pupillary examination was done and pupillary
size, shape, and regularity were documented and pupillary
light reaction tested. Although applanation tonometry and
ophthalmoscopy were carried out on each patient, these two
parameters are subjects of another report. Blood samples
were taken for full blood count, electrolyte and urea, liver
function tests, and fasting blood sugar, and haemoglobin
electrophoresis was carried out on each patient.
RESULTS
A total of 322 patients (table 1) were seen.  The male to
female ratio was 1:1.50. The patients ages ranged from 4 to
68 years. The prevalence rate of anterior segment/ adnexea
ocular manifestation was 65.2%. Conjunctival
m icroa ngiopathy was the commonest  ocula r
adnexal/anterior segment presentation. It constituted 33.8%
(highest anterior segment manifestation). Iridocyclitis was
next accounting for 27.1%, while herpes zoster ophthalmicus 
was observed in only 3.3% of the cases (see table 2). A
majority of the patients (95.1%) (tables 1 & 2, fig. 1) had
normal visual acuity at presentation to the clinic. Twelve per
cent had visual impairment, while 5.0% presented with
severe visual impairment. 
Table 1. Findings at initial presentation of patients to the
HIV/AIDS clinic
No of patients %
W ith ocular lesions 210  65.2
W ithout ocular lesions 112 34.8
Total 322 100.0





Conjunctival microangiopathy 71 33.8
Iridocyclitis 57 27.1
Molluscum contagiosum 36 17.1
Corneal ulceration 17 8.1
Squamous cell carcinoma 13 6.2
Herpes zoster ophthalmicus 7 3.3
Cataract 6 3.0
Kaposi sarcoma involving the lids,
conjunctiva and nose
3 1.4
TOTAL 210      100
Figure 1. Histogram of visual acuity of patients at presentation
at HIV clinic.
Figures 2 – 6 show ocular adnexal and anterior segment lesions
seen in HIV/AIDS patients at presentation to the clinic.
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   Figure 2. Conjunctival
   microangiopathy
   Figure 3. Molluscum
   contagiosum
   Figure 4. Advanced
   squamous cell carcinoma    Figure 5.  Herpes zoster
   ophthalmicus
     
Figure 6. Karposi sarcoma
DISCUSSION
HIV/AIDS constitutes a major threat to humanity in the 21st
century. The current national prevalence rate for Nigeria is
put at 5.8%.  Benue State, where this study was undertaken,3
has the highest prevalence rate (16.8%) among the hyper-
endemic zones of Nigeria.  This study highlights the  effects4
of HIV/AIDS on the ocular adnexal and anterior segments
of infected patients and evaluates the effect on visual
functions. The female to male ratio in this study was 1:1.5.
The prevalence rate of 65.2% for affected anterior
segment in this study is not surprising as the clinic is an
exclusively HIV/AIDS clinic, sited in a hyper-endemic area,
which also serves other hyper-endemic states like Cross
River and Kogi states. Previous studies from other zones in
Nigeria – Kaduna in the North Central zone and Ile Ife and
Benin in the South West zone – show comparatively lower
prevalence rates 12.3%, 28.8% and 21% respectively.13, 14, 17
This study showed that 95.1% of the subjects had normal
visual acuity while 1.7% had severe visual impairment. This
is in contrast to 23% bilateral blindness found by Nwosu,16
in his series from Onitsha, southeast Nigeria. This may have
been because his patients had more severe anterior segment
lesions (herpetic ulcers, ocular palsy and trauma), coupled
with advanced posterior segment lesions. 
Conjuctival microangiopathy was the most common
lesion (33.8%) seen in this series. Teish  and Egestrome,21 22
found conjunctival microangiopathy accounting for 70% and
80% in their respective studies. The main features of the
lesions were segmental vascular dilatation, corkscrew-
shaped deformities, comma-shaped vascular sections,
vascular sludging of blood, microaneurisms, dilatation and
narrowing of conjunctival vessels. There is increased plasma
viscosity, immune complex deposit and probably direct
invasion of the conjunctival endothelium by the HIV virus.
In a related microangiopathy found in the retina in other
studies,  it has been documented that the retinal23
microangiopathy was closely related to the degree of viral
load and less correlated to the degree of immunodeficiency.23
Similarly, the pathological condition of thrombotic
microangiopathy found in HIV 1 and HIV 2 infections, a
viral specific factor has been implicated in the pathogenesis
of HIV associated thrombomicroangiopathy.  Whether the24
pathogenesis postulated in the last two conditions is similar
to the aetiology of conjunctival microangiopathy seen in this
study is a subject for further studies. Less severe forms of
conjunctival microangiopathies are occasionally seen as
complications in haemoglobinopathies  and   diabetes25, 26,
mellitus.  None of the subjects in this study had sickle cell27
disease or diabetes mellitus. Nutritional anaemia could be a
possible cause of the conjunctival angiopathy seen in this
study. The average PCV of the patients at presentation to the
clinic was 25% and below.
Iridocyclitis was the second most common anterior
segment manifestation in this study. It affected 27.1% of the
patients with lesions. The majority of these cases were
idiopathic and could be part of generalized autoimmune and
endogenous uveitis. Ebanu  in Cameroon found28
iridocyclitis/uveitis the most common anterior segment
presentation in his series (18.8%). Nwosu  recorded that16
iridocyclitis/uveitis accounted for 4% in his study. Immune
recovery uveitis is a condition that is due to increased
intraocular inflammation associated  with cytomegalovirus
retinitis in patients with improved immune system following
treatment with highly active antiretroviral therapy
(HAART).  Immune recovery uveitis did not apply to29,30
subjects in this study because none of them had commenced
HAART treatment at the time of this work.
Molluscum contagiosum accounted for lesions seen in
17.1% of affected patients in this study. It is caused by a
DNA pox virus which is spread by direct contact with
infected persons or by formites. Molluscum contagiosum is
more frequent and severe in patients who are HIV positive.
In this study, 25% of the lesions were found on the lids.
Cunningham reported in his series a 5% affectation of the10 
lids by molluscum contagiosum.
52
Ocular Adnexal and Anterior Segment Manifestations of HIV/AIDS
Corneal ulceration accounted for the adnexal /anterior
segment disorders in 8.1% of  the patients in this study.
Herpes zoster keratitis leading to corneal ulcerations
accounted for 6.6% of the causative factors for corneal
ulcerations. The rest were the sequelae of corrosive herbal
medication applied to the eye for ocular complaints.
Squamous cell carcinoma accounted for ocular
manifestation of HIV/AIDS in 6.2% of affected patients. This
makes it the fifth most common ocular finding in this work.
Squamous cell carcinoma was the second most common
anterior segment lesion seen in an ophthalmic clinic in
Harare.  Two out of every hundred HIV/AIDS patients had
squamous cell carcinoma.31, 32
Contrary to the findings from previous studies13, 14, 17, 33
from other parts of the country, which found  herpes zoster
ophthalmicus to be the commonest ocular manifestation of
HIV infection, in this study it accounted for only 3.3% of
cases. It was the sixth commonest ocular adnexal and
anterior segment lesion found in this series. Even though
herpes zoster ophthalmicus is the marker for HIV infection
in Africa,  in this study, only seven (7) cases were seen16,18,19,33
out of the 210 patients with lesions. The low incidence may
not be unconnected with the fact that there are other
established centres that cater for HIV-infected patients in the
state.
Senile cataract was seen in 3% of the cases, while
complicated cataract resulting from the complications of
uveitis/iridocyclitis were seen in 66.7% of the affected
patients in this study.
Kaposi sarcoma is a highly vascular tumour appearing
as nodules on the lids, face and conjunctiva. It accounted for
lesions in 1.4% of the cases in this study. In one of the
patients, there were multiple severe lesions on the lids and
nose. Other studies  have documented Kaposi sarcoma as34
high as 25% in their findings. 
In this study, 95.1% of the patients had normal visual
acuity at recruitment point, 3.2% had visual impairment,
while 1.7% had severe visual impairment. None of the
patients presented with blindness. Female patients tended to
present with worse visual acuity compared to male patients.
This may not be unconnected with financial limitations since
most housewives depend on their husbands for medical
expenses.
CONCLUSION AND RECOMMENDATION
Herpes zoster ophthalmicus has been reported as the most
prevalent ocular and adnexal presentation of HIV infection
from earlier works.  This is at variance with the finding13,14,18,33
in this study. Conjunctival microangiopathy was the most
common ocular adnexal and anterior segment manifestation.
It accounted for 33.8% of cases. This was followed by
iridocyclitis, 27.1% and molluscum contagiosum 17.1%.
Herpes zoster ophthalmicus accounted for only 3.3% of
adnexal and anterior segment disorders. Kaposi sarcoma
was the least common accounting for 1.4% of cases. It is
apparent that most of the ocular adnexal and anterior
segment lesions seen in HIV-AIDS patients are treatable and
can be averted by timely diagnosis and management. This
will help a great deal in preventing the additional burden of
blindness with its numerous socioeconomic implications.
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